Georgetown: President David Granger is undergoing chemotherapy in the aftermath of being diagnosed with a cancer that known as Non-Hodgkin Lymphoma, government officials confirmed.
Non-Hodgkin lymphoma is a disease in which malignant (cancer) cells form in the lymph system. The major types of lymphoma are Hodgkin lymphoma and non-Hodgkin lymphoma. Non-Hodgkin lymphoma can be indolent or aggressive. Age, gender, and a weakened immune system can affect the risk of adult non-Hodgkin lymphoma.
President Granger reportedly began a second round of treatment in Cuba and is not expected to return to Guyana anytime soon.
“Subsequent to a series of medical tests, the President
was diagnosed as suffering from Non-Hodgkin Lymphoma and was placed in the
Centro de Investigaciones Medico Quirurgicas (CIMEQ) on Thursday, November 1,
where he underwent a surgical procedure,” Guyana’s Ambassador to Cuba, Halim
Majeed said in a statement. “The President’s medical personnel has now begun
the second phase of treatment on November 14, 2018, and he is likely to be
placed in CIMEQ for a short period of two to three days.”
The Cuban Envoy said that the President is expected to fully recover and
another statement would be issued before the 73 year old Head of State leaves
Cuba.
Ambassador Majeed said that the President is in a good
frame of mind and working and resting in accordance with the advice he has been
receiving from his doctors.
The President, who traveled to Cuba two weeks ago to investigate some health
concerns, is expected to remain in Cuba until the completion of his
chemotherapy treatment. A timeline for that treatment has not been provided. “Above
all, the President would like to publicly thank His Excellency, the President
of the Republic of Cuba, the Government of Cuba, and the medical staff of CIMEQ
for the special care and attention which he has received while in Havana – and,
indeed, for the excellent facilities in which he is being accommodated,” the
Cuban Envoy said in a statement.
You must be logged in to post a comment.